[Initial resistance to streptomycin, isoniazid, thiacetazone, rifampicin and ethambutol in bacilliferous tuberculosis in Maniema, Zaire].
Initial resistance to streptomycin, isoniazid, thiacetazone, rifampicin and ethambutol was tested in 102 patients with bacilliferous tuberculosis in Kalima, a rural area in eastern Zaïre. The initial resistance for at least one of these tuberculostatics was 43%. The highest resistance recorded was for streptomycin (31%). No resistance to rifampicin or ethambutol was found. The practical interest of these findings is discussed.
De Caluwé
P
P
Everaerts
M C
MC
Dufour
B
B
wa Tshalumba
M
M
D000995:Antitubercular Agents / Q000627:therapeutic use*; D015023:Democratic Republic of the Congo; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents
Résistance initiale à la streptomycine, l'isoniazide, la thiacétazone, la rifampicine et l'éthambutol chez des tuberculeux bacillifères au Maniéma, Zaïre.